Immuron (IMRN) Income towards Parent Company (2016 - 2024)

Immuron's (IMRN) quarterly Income towards Parent Company came in at -$1.6 million in Q4 2024, up 21.49% year-on-year from -$1.3 million in Q1 2024, and up 21.49% quarter-over-quarter from -$2.1 million in Q4 2023.

Immuron (IMRN) Income towards Parent Company (2016 - 2024) Analysis & Trends

Immuron's Income towards Parent Company history runs 9 years deep, the most recent figure standing at -$1.6 million for Q4 2024.

  • On a quarterly basis, Income towards Parent Company rose 21.49% year-over-year to -$1.6 million in Q4 2024; TTM through Sep 2025 was -$1.6 million, a 21.49% increase from a year earlier, with the FY2025 full-year figure at -$3.4 million, down 227575.8% from the prior year.
  • Income towards Parent Company grew to -$1.6 million in Q4 2024 per IMRN's latest filing, from -$2.1 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at -$13260.2 in Q4 2021 and bottomed at -$2.1 million in Q4 2023.
  • The 5-year median for Income towards Parent Company is -$795595.5 (2022), against an average of -$893766.8.
  • Across the five-year window, Income towards Parent Company jumped 76.89% in 2021 and tumbled 2558.11% in 2022, its largest moves.
  • Year by year, Income towards Parent Company stood at -$57387.7 in 2020, then soared by 76.89% to -$13260.2 in 2021, then tumbled by 2558.11% to -$352470.5 in 2022, then slumped by 488.19% to -$2.1 million in 2023, then advanced by 21.49% to -$1.6 million in 2024.
  • Per Business Quant, the three latest IMRN Income towards Parent Company figures stand at -$1.6 million (Q4 2024), -$2.1 million (Q4 2023), and -$1.2 million (Q2 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Immuron 255.19 Mn 243.53 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.63 Mn
Dec 31, 2023 -2.07 Mn
Jun 30, 2023 -1.24 Mn
Dec 31, 2022 -352,470.52
Dec 31, 2021 -13,260.17
Dec 31, 2020 -57,387.72
Dec 31, 2019 -15,212.27
Dec 31, 2018 -1.58 Mn
Dec 31, 2017 -1.45 Mn
Dec 31, 2016 -2.60 Mn
Jun 30, 2016 -3.28 Mn